Verastem Inc banner

Verastem Inc
F:2VS

Watchlist Manager
Verastem Inc Logo
Verastem Inc
F:2VS
Watchlist
Price: 9.828 EUR Market Closed
Market Cap: €2.1B

Wall St Price Targets

2VS Price Targets Summary
Verastem Inc

Wall Street analysts forecast 2VS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 2VS is 28.16 EUR with a low forecast of 25.024 EUR and a high forecast of 32.953 EUR.

Lowest Forecast
Price Target
25.024 EUR
155% Upside
Average Forecast
Price Target
28.16 EUR
187% Upside
Highest Forecast
Price Target
32.953 EUR
235% Upside
Verastem Inc Competitors:
Price Targets
ACAD
ACADIA Pharmaceuticals Inc
48% Upside
TTD
Trade Desk Inc
44% Upside
CFFN
Capitol Federal Financial Inc
3% Upside

Revenue
Forecast

N/A
Past Growth
54% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
54% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

The compound annual growth rate for Revenue over the next 8 years is 54%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-94%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-94%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 2VS's stock price target?
Price Target
28.16 EUR

According to Wall Street analysts, the average 1-year price target for 2VS is 28.16 EUR with a low forecast of 25.024 EUR and a high forecast of 32.953 EUR.

What is the Revenue forecast for Verastem Inc?
Projected CAGR
54%

The compound annual growth rate for Revenue over the next 8 years is 54%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett